| Code | 21707 | ||||||||||
| MA number | EU/1/10/638/001 | ||||||||||
| Product Form: | imp ivt 1x700 µg (vrecko s aplik.syst.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | AbbVie Deutschland GmbH & Co. KG, Germany | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | sachet with administration system | ||||||||||
| Route of admin.: | Intravitreal use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 27.07.2010 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Ozurdex Príručka pre pacienta.pdf
|
| Safety feature | Yes |
| Data update: | 22.06.2022 |
